{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T08:18:27Z","timestamp":1783412307693,"version":"3.54.6"},"reference-count":57,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"1","funder":[{"name":"Faculty of Medicine Ramathibodi Hospital, Mahidol University","award":["RF_67063"],"award-info":[{"award-number":["RF_67063"]}]}],"content-domain":{"domain":["spj.science.org"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2026,3,1]]},"abstract":"<jats:p>\n                    Poly(adenosine diphosphate-ribose) polymerase 1 (PARP1) is a pivotal target for treating homologous recombination-deficient cancers through the mechanism of synthetic lethality. While machine learning has accelerated the identification of novel inhibitors, many models lack experimental validation and high-resolution mechanistic insights. In this study, we evaluated the predictive robustness of the PARP1pred model using a hierarchical pipeline. Initial bioactivity predictions for candidates in unseen chemical space were validated through biochemical and cellular sensitivity assays using a panel of isogenic TK6 cell lines. Subsequently, molecular docking, 100-ns molecular dynamics simulations, and molecular mechanics Poisson\u2013Boltzmann surface area (MM-PBSA) energetic analysis were performed to provide a structural and thermodynamic rationale for the observed inhibitory potencies. The workflow successfully identified ZINC49069486 as a highly potent nanomolar lead that induced selective synthetic lethality in BRCA1-deficient cells. Crucially, the pipeline correctly classified ZINC67913374 as biologically inactive [median inhibitory concentration (IC\n                    <jats:sub>50<\/jats:sub>\n                    ) &gt; 100 \u03bcM], successfully identifying a false positive previously proposed in the literature as a potential inhibitor. MM-PBSA analysis revealed that the inactivity of ZINC67913374 was driven by an excessive polar solvation penalty that outweighed its favorable docking score. While ZINC98208034 and ZINC8793749 showed moderate enzymatic inhibition, they failed to induce a synthetic lethality response. These results confirm that the PARP1pred-driven hierarchical framework effectively prioritizes experimentally validated lead compound while filtering out deceptive computational hits, providing an accessible and robust strategy for PARP1 inhibitor discovery.\n                  <\/jats:p>","DOI":"10.34133\/csbj.0152","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:20:29Z","timestamp":1780957229000},"update-policy":"https:\/\/doi.org\/10.34133\/aaas_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Experimental and Mechanistic Validation of PARP1pred for Identifying Potent Leads"],"prefix":"10.34133","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8149-0341","authenticated-orcid":false,"given":"Sermsiri","family":"Chitphuk","sequence":"first","affiliation":[{"name":"Research Center, Faculty of Medicine Ramathibodi Hospital, \rMahidol University, Bangkok 10400, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2234-4317","authenticated-orcid":false,"given":"Wasana","family":"Stitchantrakul","sequence":"additional","affiliation":[{"name":"Research Center, Faculty of Medicine Ramathibodi Hospital, \rMahidol University, Bangkok 10400, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2886-5415","authenticated-orcid":false,"given":"Rakkreat","family":"Wikiniyadhanee","sequence":"additional","affiliation":[{"name":"Program in Translational Medicine, Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, \rMahidol University, Samut Prakan 10540, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8367-9415","authenticated-orcid":false,"given":"Donniphat","family":"Dejsuphong","sequence":"additional","affiliation":[{"name":"Program in Translational Medicine, Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, \rMahidol University, Samut Prakan 10540, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9250-661X","authenticated-orcid":true,"given":"Kanchanok","family":"Kodchakorn","sequence":"additional","affiliation":[{"name":"Computational Simulation and Modelling Laboratory (CSML), Department of Chemistry, Faculty of Science, \rChiang Mai University, Chiang Mai 50200, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9526-951X","authenticated-orcid":true,"given":"Tassanee","family":"Lerksuthirat","sequence":"additional","affiliation":[{"name":"Research Center, Faculty of Medicine Ramathibodi Hospital, \rMahidol University, Bangkok 10400, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2022.02.021"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2020.02.002"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2021.01.014"},{"issue":"1","key":"e_1_3_4_5_2","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41392-021-00648-7","article-title":"DNA damage repair: Historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy","volume":"6","author":"Huang R","year":"2021","unstructured":"Huang R, Zhou PK. DNA damage repair: Historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy. Signal Transduct Target Ther. 2021;6(1):254.","journal-title":"Signal Transduct Target Ther"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2021.103125","article-title":"PARP1: Structural insights and pharmacological targets for inhibition","volume":"103","author":"Spiegel JO","year":"2021","unstructured":"Spiegel JO, Van Houten B, Durrant JD. PARP1: Structural insights and pharmacological targets for inhibition. DNA Repair. 2021;103: Article 103125.","journal-title":"DNA Repair"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15716"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010041"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.12.012"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13153819"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.3390\/biom14101269"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-03227-6"},{"key":"e_1_3_4_13_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.108058","article-title":"Poly (ADP-ribose) polymerase (PARP) inhibitors approved for the treatment of cancer","volume":"222","author":"Roskoski R","year":"2025","unstructured":"Roskoski R. Poly (ADP-ribose) polymerase (PARP) inhibitors approved for the treatment of cancer. Pharmacol Res. 2025;222: Article 108058.","journal-title":"Pharmacol Res"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02326-7"},{"issue":"1","key":"e_1_3_4_15_2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s12609-025-00582-5","article-title":"Targeting PARP1: A promising approach for next-generation poly (ADP-ribose) polymerase inhibitors","volume":"17","author":"Ray A","year":"2025","unstructured":"Ray A, Opyrchal M. Targeting PARP1: A promising approach for next-generation poly (ADP-ribose) polymerase inhibitors. Curr Breast Cancer Rep. 2025;17(1):22.","journal-title":"Curr Breast Cancer Rep"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113705","article-title":"Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review","volume":"224","author":"Sabe VT","year":"2021","unstructured":"Sabe VT, Ntombela T, Jhamba LA, Maguire GE, Govender T, Naicker T, Kruger HG. Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review. Eur J Med Chem. 2021;224: Article 113705.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"e_1_3_4_17_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.aichem.2023.100039","article-title":"Advances in artificial intelligence (AI)-assisted approaches in drug screening","volume":"2","author":"Singh S","year":"2024","unstructured":"Singh S, Gupta H, Sharma P, Sahi S. Advances in artificial intelligence (AI)-assisted approaches in drug screening. Artif Intell Chem. 2024;2(1): Article 100039.","journal-title":"Artif Intell Chem"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"1362456","DOI":"10.3389\/fddsv.2024.1362456","article-title":"Integrative computational approaches for discovery and evaluation of lead compound for drug design","volume":"4","author":"Naithani U","year":"2024","unstructured":"Naithani U, Guleria V. Integrative computational approaches for discovery and evaluation of lead compound for drug design. Front Drug Discov. 2024;4:1362456.","journal-title":"Front Drug Discov"},{"issue":"2","key":"e_1_3_4_19_2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/ijms17020258","article-title":"In silico screening identifies a novel potential PARP1 inhibitor targeting synthetic lethality in cancer treatment","volume":"17","author":"Li J","year":"2016","unstructured":"Li J, Zhou N, Cai P, Bao J. In silico screening identifies a novel potential PARP1 inhibitor targeting synthetic lethality in cancer treatment. Int J Mol Sci. 2016;17(2):258.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_4_20_2","doi-asserted-by":"crossref","first-page":"1026306","DOI":"10.3389\/fphar.2022.1026306","article-title":"Discovery of novel anti-tumor compounds targeting PARP-1 with induction of autophagy through in silico and in\u00a0vitro screening","volume":"13","author":"Shi D","year":"2022","unstructured":"Shi D, Pang Q, Qin Q, Yao X, Yao X, Yu Y. Discovery of novel anti-tumor compounds targeting PARP-1 with induction of autophagy through in silico and in\u00a0vitro screening. Front Pharmacol. 2022;13:1026306.","journal-title":"Front Pharmacol"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16203441"},{"issue":"1","key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"12764","DOI":"10.1038\/s41598-025-97208-8","article-title":"Integrating machine learning driven virtual screening and molecular dynamics simulations to identify potential inhibitors targeting PARP1 against prostate cancer","volume":"15","author":"Aldakheel FM","year":"2025","unstructured":"Aldakheel FM, Alduraywish SA, Dabwan KH. Integrating machine learning driven virtual screening and molecular dynamics simulations to identify potential inhibitors targeting PARP1 against prostate cancer. Sci Rep. 2025;15(1):12764.","journal-title":"Sci Rep"},{"key":"e_1_3_4_23_2","first-page":"84","article-title":"PARP1pred: A web server for screening the bioactivity of inhibitors against DNA repair enzyme PARP-1","volume":"22","author":"Lerksuthirat T","year":"2023","unstructured":"Lerksuthirat T, Chitphuk S, Stitchantrakul W, Dejsuphong D, Malik AA, Nantasenamat C. PARP1pred: A web server for screening the bioactivity of inhibitors against DNA repair enzyme PARP-1. EXCLI J. 2023;22:84\u2013107.","journal-title":"EXCLI J"},{"issue":"12","key":"e_1_3_4_24_2","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1021\/acs.jcim.0c00675","article-title":"ZINC20-a free ultralarge-scale chemical database for ligand discovery","volume":"60","author":"Irwin JJ","year":"2020","unstructured":"Irwin JJ, Tang KG, Young J, Dandarchuluun C, Wong BR, Khurelbaatar M, Moroz YS, Mayfield J, Sayle RA. ZINC20-a free ultralarge-scale chemical database for ligand discovery. J Chem Inf Model. 2020;60(12):6065\u20136073.","journal-title":"J Chem Inf Model"},{"issue":"11","key":"e_1_3_4_25_2","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3390\/biom14111382","article-title":"\u0391-Mangostin: A Xanthone derivative in Mangosteen with potent anti-cancer properties","volume":"14","author":"Majdalawieh AF","year":"2024","unstructured":"Majdalawieh AF, Terro TM, Ahari SH, Abu-Yousef IA. \u0391-Mangostin: A Xanthone derivative in Mangosteen with potent anti-cancer properties. Biomolecules. 2024;14(11):1382.","journal-title":"Biomolecules"},{"issue":"5","key":"e_1_3_4_26_2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3390\/biom15050681","article-title":"\u03b1-Mangostin is a Xanthone derivative from Mangosteen with potent immunomodulatory and anti-inflammatory properties","volume":"15","author":"Majdalawieh AF","year":"2025","unstructured":"Majdalawieh AF, Khatib BK, Terro TM. \u03b1-Mangostin is a Xanthone derivative from Mangosteen with potent immunomodulatory and anti-inflammatory properties. Biomolecules. 2025;15(5):681.","journal-title":"Biomolecules"},{"issue":"45","key":"e_1_3_4_27_2","doi-asserted-by":"crossref","first-page":"E10642","DOI":"10.1073\/pnas.1803177115","article-title":"BRCA1 ensures genome integrity by eliminating estrogen-induced pathological topoisomerase II-DNA complexes","volume":"115","author":"Sasanuma H","year":"2018","unstructured":"Sasanuma H, Tsuda M, Morimoto S, Saha LK, Rahman MM, Kiyooka Y, Fujiike H, Cherniack AD, Itou J, Callen Moreu E, et al. BRCA1 ensures genome integrity by eliminating estrogen-induced pathological topoisomerase II-DNA complexes. Proc Natl Acad Sci USA. 2018;115(45):E10642\u2013E10651.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"e_1_3_4_28_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101027","article-title":"UBC13-mediated ubiquitin signaling promotes removal of blocking adducts from DNA double-strand breaks","volume":"23","author":"Akagawa R","year":"2020","unstructured":"Akagawa R, Trinh HT, Saha LK, Tsuda M, Hirota K, Yamada S, Shibata A, Kanemaki MT, Nakada S, Takeda S, et al. UBC13-mediated ubiquitin signaling promotes removal of blocking adducts from DNA double-strand breaks. IScience. 2020;23(4): Article 101027.","journal-title":"IScience"},{"issue":"1","key":"e_1_3_4_29_2","doi-asserted-by":"crossref","first-page":"7891753","DOI":"10.1155\/2023\/7891753","article-title":"ATR inhibitor synergizes PARP inhibitor cytotoxicity in homologous recombination repair deficiency TK6 cell lines","volume":"2023","author":"Wikiniyadhanee R","year":"2023","unstructured":"Wikiniyadhanee R, Lerksuthirat T, Stitchantrakul W, Chitphuk S, Takeda S, Dejsuphong D. ATR inhibitor synergizes PARP inhibitor cytotoxicity in homologous recombination repair deficiency TK6 cell lines. Biomed Res Int. 2023;2023(1):7891753.","journal-title":"Biomed Res Int"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b00990"},{"issue":"1","key":"e_1_3_4_31_2","first-page":"57","article-title":"Python: A programming language for software integration and development","volume":"17","author":"Sanner MF","year":"1999","unstructured":"Sanner MF. Python: A programming language for software integration and development. J Mol Graph Model. 1999;17(1):57\u201361.","journal-title":"J Mol Graph Model"},{"issue":"20","key":"e_1_3_4_32_2","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1021\/acs.jcim.3c01153","article-title":"AmberTools","volume":"63","author":"Case DA","year":"2023","unstructured":"Case DA, Aktulga HM, Belfon K, Cerutti DS, Cisneros GA, Cruzeiro VW, Forouzesh N, Giese TJ, Gotz AW, Gohlke H, et al. AmberTools. J Chem Inf Model. 2023;63(20):6183\u20136191.","journal-title":"J Chem Inf Model"},{"issue":"2","key":"e_1_3_4_33_2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott O","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455\u2013461.","journal-title":"J Comput Chem"},{"key":"e_1_3_4_34_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2020.107717","article-title":"Molecular modelling investigation for drugs and nutraceuticals against protease of SARS-CoV-2","volume":"101","author":"Kodchakorn K","year":"2020","unstructured":"Kodchakorn K, Poovorawan Y, Suwannakarn K, Kongtawelert P. Molecular modelling investigation for drugs and nutraceuticals against protease of SARS-CoV-2. J Mol Graph Model. 2020;101: Article 107717.","journal-title":"J Mol Graph Model"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2025.01.001"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jctc.9b00591"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1021\/ct200909j"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1021\/ct400341p"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.9b00055"},{"key":"e_1_3_4_40_2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-62703-658-0_11","volume-title":"Protein dynamics: Methods and protocols","author":"David CC","year":"2014","unstructured":"David CC, Jacobs DJ. Principal component analysis: A method for determining the essential dynamics of proteins. In: Livesay DR, editor. Protein dynamics: Methods and protocols. Totowa (NJ): Humana Press; 2014. p. 193\u2013226."},{"issue":"11","key":"e_1_3_4_41_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277745","article-title":"Molecular dynamics study on the strengthening behavior of Delta and omicron SARS-CoV-2 spike RBD improved receptor-binding affinity","volume":"17","author":"Kodchakorn K","year":"2022","unstructured":"Kodchakorn K, Kongtawelert P. Molecular dynamics study on the strengthening behavior of Delta and omicron SARS-CoV-2 spike RBD improved receptor-binding affinity. PLOS ONE. 2022;17(11): Article e0277745.","journal-title":"PLOS ONE"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.3390\/ph18111679"},{"issue":"1","key":"e_1_3_4_43_2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0014-5793(03)01362-0","article-title":"Inhibitor-induced structural change of the active site of human poly(ADP-ribose) polymerase","volume":"556","author":"Kinoshita T","year":"2004","unstructured":"Kinoshita T, Nakanishi I, Warizaya M, Iwashita A, Kido Y, Hattori K, Fujii T. Inhibitor-induced structural change of the active site of human poly(ADP-ribose) polymerase. FEBS Lett. 2004;556(1-3):43\u201346.","journal-title":"FEBS Lett"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910829"},{"issue":"1","key":"e_1_3_4_45_2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s43556-025-00385-1","article-title":"PARPs and PARP inhibitors: Molecular mechanisms and clinical applications","volume":"6","author":"Wang F","year":"2025","unstructured":"Wang F, Guo Z, Carr MJ, Shi W. PARPs and PARP inhibitors: Molecular mechanisms and clinical applications. Mol Biomed. 2025;6(1):152.","journal-title":"Mol Biomed"},{"issue":"1","key":"e_1_3_4_46_2","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gky1075","article-title":"ChEMBL: Towards direct deposition of bioassay data","volume":"47","author":"Mendez D","year":"2019","unstructured":"Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, F\u00e9lix E, Magari\u00f1os MP, Mosquera JF, Mutowo P, Nowotka M, et al. ChEMBL: Towards direct deposition of bioassay data. Nucleic Acids Res. 2019;47(D1):D930\u2013D940.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf7175"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax6367"},{"issue":"23","key":"e_1_3_4_49_2","doi-asserted-by":"crossref","first-page":"9556","DOI":"10.1021\/jm401394u","article-title":"Chemical probes to study ADP-ribosylation: Synthesis and biochemical evaluation of inhibitors of the human ADP-ribosyltransferase ARTD3\/PARP3","volume":"56","author":"Lindgren AEG","year":"2013","unstructured":"Lindgren AEG, Karlberg T, Ekblad T, Spjut S, Thorsell AG, Andersson CD, Nhan TT, Hellsten V, Weigelt J, Linusson A, et al. Chemical probes to study ADP-ribosylation: Synthesis and biochemical evaluation of inhibitors of the human ADP-ribosyltransferase ARTD3\/PARP3. J Med Chem. 2013;56(23):9556\u20139568.","journal-title":"J Med Chem"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1216338"},{"issue":"10","key":"e_1_3_4_51_2","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.3390\/ijms22105112","article-title":"PARP power: A structural perspective on PARP1, PARP2, and PARP3 in DNA damage repair and nucleosome remodelling","volume":"22","author":"Beek L","year":"2021","unstructured":"van Beek L, McClay \u00c9, Patel S, Schimpl M, Spagnolo L, Maia de Oliveira T. PARP power: A structural perspective on PARP1, PARP2, and PARP3 in DNA damage repair and nucleosome remodelling. Int J Mol Sci. 2021;22(10):5112.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-025-11119-4"},{"issue":"1","key":"e_1_3_4_53_2","first-page":"40","article-title":"Comprehensive machine learning boosts structure-based virtual screening for PARP1 inhibitors","volume":"16","author":"Caba K","year":"2024","unstructured":"Caba K, Tran-Nguyen VK, Rahman T, Ballester PJ. Comprehensive machine learning boosts structure-based virtual screening for PARP1 inhibitors. J Chem. 2024;16(1):40.","journal-title":"J Chem"},{"key":"e_1_3_4_54_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2025.2544217","article-title":"Integrating diffusion models and molecular modeling for PARP1 inhibitors generation","author":"Nguyen TK","year":"2025","unstructured":"Nguyen TK, Nguyen TT, Pham KH, Luong MT, Trong Tai H, Tuyet Mai DT, Nguyen NH. Integrating diffusion models and molecular modeling for PARP1 inhibitors generation. J Biomol Struct Dyn. 2025;1\u201315.","journal-title":"J Biomol Struct Dyn"},{"key":"e_1_3_4_55_2","doi-asserted-by":"crossref","first-page":"971369","DOI":"10.3389\/fphar.2022.971369","article-title":"A multi-task FP-GNN framework enables accurate prediction of selective PARP inhibitors","volume":"13","author":"Ai D","year":"2022","unstructured":"Ai D, Wu J, Cai H, Zhao D, Chen Y, Wei J, Xu J, Zhang J, Wang L. A multi-task FP-GNN framework enables accurate prediction of selective PARP inhibitors. Front Pharmacol. 2022;13:971369.","journal-title":"Front Pharmacol"},{"issue":"8","key":"e_1_3_4_56_2","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1158\/1538-7445.AM2025-4186","article-title":"Abstract 4186: Discovery of novel PARP1-selective inhibitors for treatment of brain tumors using artificial intelligence","volume":"85","author":"Truong S","year":"2025","unstructured":"Truong S, Zhai B, Ramos L, Marzban M, Ghaidi F, Ban F, Smith J, Pandey M, Manskaia E, Singh K, et al. Abstract 4186: Discovery of novel PARP1-selective inhibitors for treatment of brain tumors using artificial intelligence. Cancer Res. 2025;85(8_Supplement_1):4186.","journal-title":"Cancer Res"},{"issue":"5","key":"e_1_3_4_57_2","first-page":"v151","article-title":"Discovery and development of novel CNS-penetrating PARP1-selective inhibitors","volume":"27","author":"Bacha J","year":"2025","unstructured":"Bacha J, Truong S, Ban F, Smith J, Pandey M, Manskaia E, Zhai B, Ramos L, Marzban M, Ghaidi F, et al. Discovery and development of novel CNS-penetrating PARP1-selective inhibitors. Neuro-Oncology. 2025;27(Supplement_5):v151\u2013v152.","journal-title":"Neuro-Oncology"},{"issue":"1","key":"e_1_3_4_58_2","doi-asserted-by":"crossref","first-page":"10127","DOI":"10.1038\/s41467-024-54456-y","article-title":"ClickGen: Directed exploration of synthesizable chemical space via modular reactions and reinforcement learning","volume":"15","author":"Wang M","year":"2024","unstructured":"Wang M, Li S, Wang J, Zhang O, Du H, Jiang D, Wu Z, Deng Y, Kang Y, Pan P, et al. ClickGen: Directed exploration of synthesizable chemical space via modular reactions and reinforcement learning. Nat Commun. 2024;15(1):10127.","journal-title":"Nat Commun"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.34133\/csbj.0152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T08:01:44Z","timestamp":1783411304000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.34133\/csbj.0152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3,1]]}},"alternative-id":["10.34133\/csbj.0152"],"URL":"https:\/\/doi.org\/10.34133\/csbj.0152","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,1]]},"assertion":[{"value":"2026-03-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"0152"}}